Article
Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basis.
The Journal of pharmacology and experimental therapeutics - 1 Jul 1995
Dahl M L, Johansson I, Bertilsson L, Ingelman-Sundberg M, Sjöqvist F
Abstract excerpt
Hydroxylation of debrisoquine, catalyzed by the cytochrome P450 CYP2D6 exhibits genetic polymorphism, with large inter-individual differences in metabolic capacity. About 7% of Caucasians carry deficient CYP2D6 alleles and lack the CYP2D6 enzyme (poor metabolizers). We have shown in two Swedish families, individuals carrying duplicated or amplified functional CYP2D6L-genes (CYP2D6L2), causing the opposite...
Topics
- Cytochrome P-450 CYP2D6
- Cytochrome P-450 Enzyme System
- Debrisoquin
- Gene Amplification
- Genetics, Population
- Haplotypes
- Heterozygote
- Homozygote
- Humans
- Hydroxylation
- Mixed Function Oxygenases
